Perbedaan Catur Sentosa Adiprana Tbk. dan Tempo Scan Pacific Tbk.: Catur Sentosa Adiprana Tbk. diperdagangkan di Rp294 (kapitalisasi pasar 1,66 T, volume 24 jam 5,76 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T, volume 24 jam 809,6 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 7,6× kapitalisasi pasar Catur Sentosa Adiprana Tbk., dan Catur Sentosa Adiprana Tbk. lebih aktif diperdagangkan (5,76 jt vs 809,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CSAP | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 1,66 T | 12,58 T |
Volume | 5,76 jt | 809,6 rb |
Lot | 57,64 rb | 8,1 rb |
Perputaran | 1,89 M | 2,26 M |
Harga Rata-rata | 328,51 | 2.786,16 |
Nilai Transaksi | 1,89 M | 2,26 M |
Harga Ekuilibrium Indikatif | 294 | 2.790 |
Volume Ekuilibrium Indikatif | 258 | 1,63 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Catur Sentosa Adiprana Tbk (the company) was established on 31 Dec 1983 based on Notaries Deed No. 93 and the deed of establishment was approved by the the Ministry of Justice dated Sep 18, 1983. Based on the Company’s stockholders’ circular resolution dated June 6, 2007, the stockholders approved the change in the legal status of the Company from a Limited Liability Company “Perseroan Terbatas” with Foreign Capital Investments facility to a Limited Liability Company “Perseroan Terbatas” with Non-Foreign Capital Investments facility/Domestic Capital Investments, including the revocation and/or cancellation of every existing agreement of the Company related to Foreign Capital Investments.
Selengkapnya di halaman CSAP →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →